Sat.Jun 25, 2022

article thumbnail

Gene variants may affect length of survival in Parkinson’s patients, new study shows

Scienmag

(Vienna, Sunday, 26 June 2022) How long someone lives with Parkinson’s disease may be down to specific gene mutations, according to new research presented today at the 8th European Academy of Neurology (EAN) Congress.1 Scientists from four institutes in Paris, including the prestigious Paris Brain Institute at the Sorbonne Université, studied the records of 2,037 […].

Gene 88
article thumbnail

New patent expiration for Merck Sharp drug JUVISYNC

Drug Patent Watch

Annual Drug Patent Expirations for JUVISYNC Juvisync is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are four patents protecting this drug and three…. The post New patent expiration for Merck Sharp drug JUVISYNC appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Climate damage caused by growing space tourism needs urgent mitigation

Scienmag

Published today in the journal Earth’s Future, researchers from UCL, the University of Cambridge and Massachusetts Institute of Technology (MIT) used a 3D model to explore the impact of rocket launches and re-entry in 2019, and the impact of projected space tourism scenarios based on the recent billionaire space race. The team found that black carbon […].

article thumbnail

Drug Patent Expirations for the Week of June 26, 2022

Drug Patent Watch

PRADAXA (dabigatran etexilate mesylate) Boehringer ingelheim Patent: 6,087,380 Expiration: Jun 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…. The post Drug Patent Expirations for the Week of June 26, 2022 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Undiagnosed major risk factors found in two thirds of ischaemic stroke patients, new study reveals

Scienmag

(Vienna, Sunday, 26 June, 2022) People who suffer from ischaemic strokes with no previously diagnosed risk factors have been found to have underlying conditions in the majority of cases, a new study presented today at the European Academy of Neurology (EAN) Congress 2022 has shown.1 Overall, the study identified 67.7% of stroke patients with previously […].

65
article thumbnail

Which pharmaceutical companies have the most suspension dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…. The post Which pharmaceutical companies have the most suspension dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40